Natco Pharma Ltd - Share Price
NATCOPHARM
Natco Pharma LtdFinancials
Natco Pharma LtdNews & Updates
Natco Pharma stock extends loss as Delhi HC upholds interim injunction plea of FMC Corp
Jul 08,2021 02:39 PM
Delhi HC orally pronounced judgment in the interim injunction application filed by FMC Corporation on CTPR.
Natco Pharma tumbles after Delhi HC allows injuction application by FMC Corp Jul 07,2021
Natco Pharma Jun 18,2021
Natco Pharma slips on weak Q4 outcome Jun 18,2021
Natco Pharma consolidated net profit declines 43.68% in the March 2021 quarter Jun 17,2021
Natco Pharma Q4 PAT declines to Rs53cr, revenue down to Rs359.7cr Jun 17,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 703.40 | 74.70 | 166,513.85 | 327.39 | 1.08 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,921.15 | 65.52 | 128,060.72 | 487.93 | 0.41 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,411.25 | 48.78 | 90,215.55 | 311.50 | 0.46 | 3,313.50 | 1,032.72 |
| Cipla Ltd | 950.55 | 30.98 | 76,469.70 | 413.41 | 0.53 | 3,173.39 | 247.04 |
| Gland Pharma Ltd | 4,019.25 | 63.79 | 65,961.75 | 350.68 | 0.00 | 1,153.90 | 359.44 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Natco Pharma LtdSummary & Reports
No Company Summary found
Registered Office
Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033
Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in
Registrar Office
12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA
Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com
Reports by natco-pharma-ltd-share-price
Latest Release by natco-pharma-ltd-share-price
Result Express
Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates
Jul 26, 2021 07:01 PM
The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.
Shareholding Snapshot
Loading ...
| Jun - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 48.87% |
| Total Promoter | 48.87% |
| Non Promoter | - |
| Institutions | 29.94% |
| Non-Institutions | 21.19% |
| Total Non-Promoter | 51.13% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
17 Jun 2021
Annc. Date
08 Jun 2021
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
Purpose
Board Meeting
Exp. Date
26 Mar 2021
Annc. Date
26 Mar 2021
To acquire 0.96% stake in NATCO Pharma (Canada) Inc., after this acquisition NATCO Pharma (Canada) I... More
Purpose
Dividend
Annc. Date
11 Feb 2021
Effective. Date
22 Feb 2021
Divi. Type
Interim 3
Divi.(%)
50
Divi. Amt.
1
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More
Purpose
Board Meeting
Exp. Date
11 Feb 2021
Annc. Date
03 Feb 2021
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
